Vicapsys Life Sciences, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
Vicapsys Life Sciences reported a net loss of $752,670 for the nine months ended September 30, 2024, and faces substantial doubt about its ability to continue as a going concern.
OTC.Pink
Vicapsys Life Sciences reported no revenue and a net loss for the second quarter of 2024, highlighting ongoing financial challenges and a need for additional funding.
OTC.Pink
Vicapsys Life Sciences reports a net loss for Q1 2024 and expresses substantial doubt about its ability to continue as a going concern.